DuChemBIO Statistics

Total Valuation

DuChemBIO has a market cap or net worth of KRW 371.34 billion. The enterprise value is 378.20 billion.

Market Cap	371.34B
Enterprise Value	378.20B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

DuChemBIO has 28.46 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	28.46M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	9.25%
Owned by Institutions (%)	n/a
Float	10.60M

Valuation Ratios

The trailing PE ratio is 43.79.

PE Ratio	43.79
Forward PE	n/a
PS Ratio	9.83
PB Ratio	8.14
P/TBV Ratio	15.36
P/FCF Ratio	68.27
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 32.19, with an EV/FCF ratio of 69.53.

EV / Earnings	47.31
EV / Sales	10.62
EV / EBITDA	32.19
EV / EBIT	61.17
EV / FCF	69.53

Financial Position

The company has a current ratio of 1.49, with a Debt / Equity ratio of 0.41.

Current Ratio	1.49
Quick Ratio	1.40
Debt / Equity	0.41
Debt / EBITDA	1.65
Debt / FCF	3.23
Interest Coverage	4.65

Financial Efficiency

Return on equity (ROE) is 24.67% and return on invested capital (ROIC) is 6.09%.

Return on Equity (ROE)	24.67%
Return on Assets (ROA)	5.54%
Return on Invested Capital (ROIC)	6.09%
Return on Capital Employed (ROCE)	10.10%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.62
Inventory Turnover	17.90

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +43.84% in the last 52 weeks. The beta is -0.15, so DuChemBIO's price volatility has been lower than the market average.

Beta (5Y)	-0.15
52-Week Price Change	+43.84%
50-Day Moving Average	15,408.80
200-Day Moving Average	11,621.55
Relative Strength Index (RSI)	27.83
Average Volume (20 Days)	1,199,908

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, DuChemBIO had revenue of KRW 35.60 billion and earned 7.99 billion in profits. Earnings per share was 298.00.

Revenue	35.60B
Gross Profit	12.23B
Operating Income	5.08B
Pretax Income	5.56B
Net Income	7.99B
EBITDA	10.64B
EBIT	5.08B
Earnings Per Share (EPS)	298.00

Full Income Statement

Balance Sheet

The company has 10.69 billion in cash and 17.55 billion in debt, giving a net cash position of -6.86 billion or -241.13 per share.

Cash & Cash Equivalents	10.69B
Total Debt	17.55B
Net Cash	-6.86B
Net Cash Per Share	-241.13
Equity (Book Value)	43.01B
Book Value Per Share	1,603.36
Working Capital	7.31B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 7.03 billion and capital expenditures -1.59 billion, giving a free cash flow of 5.44 billion.

Operating Cash Flow	7.03B
Capital Expenditures	-1.59B
Free Cash Flow	5.44B
FCF Per Share	191.17

Full Cash Flow Statement

Margins

Gross margin is 34.36%, with operating and profit margins of 14.26% and 22.45%.

Gross Margin	34.36%
Operating Margin	14.26%
Pretax Margin	15.63%
Profit Margin	22.45%
EBITDA Margin	29.89%
EBIT Margin	14.26%
FCF Margin	15.28%

Dividends & Yields

DuChemBIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	2.15%
FCF Yield	1.46%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

DuChemBIO has an Altman Z-Score of 8.97.

Altman Z-Score	8.97
Piotroski F-Score	n/a